The Peruvian government has abandoned the coronavirus vaccine being developed by the British-Swedish pharmaceutical company AstraZeneca after the death of one of the volunteers involved in the trials. This was reported by the country's Ministry of Health, RIA Novosti reports.
As noted in the department, the government will not sign an agreement with AstraZeneca due to lack of information on clinical trials. They also recalled the death of one of the test participants. “All countries are willing to take some risk with the vaccine, but not a big risk,” said Peruvian Minister of Health Pilar Massetti.
On October 21, Brazil's National Health Surveillance Agency announced the death of a 28-year-old test taker “as a result of complications from COVID-19.” Later it became known that the man, as part of the trial, received not a drug, but a placebo. After the death of the volunteer, they decided to continue testing the vaccine.
A total of 8,000 people in Brazil are participating in AstraZeneca's international drug research program. Of these, only half receive a real vaccine.